Contact
 

Novel Approaches, Including Systems Biology, To HIV Vaccine Research and Development Working Group Members

John Aitchison US Institute for Systems Biology
Paul de Bakker US Brigham and Women's Hospital Broad Institute of MIT and Harvard
Luigi Buonaguro Italy Istituto Nazionale Tumori "Fond. G. Pascale"
Brian Chait US The Rockefeller University
Nicole Doria-Rose US National Institute of Allergy and Infectious Diseases, NIH
Alan Embry US Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH
Ronald Germain US National Institute of Allergy and Infectious Diseases, NIH
Don Gerson US PnuVax
David Ho US Aaron Diamond AIDS Research Center
Thomas Hope US Northwestern University
Antonio Lanzavecchia Switzerland Institute for Research in Biomedicine
Francine McCutchan US Bill & Melinda Gates Foundation
Adrian McDermott US IAVI
Matthew Moyle US Theraclone Sciences
Chris Petropoulos US Monogram Biosciences
Rafick-Pierre Sékaly Canada McGill University and INSERM Unit 743
Bill Schief US University of Washington
Steve Self US Statistical Center for HIV/AIDS Research & Prevention
Robin Shattock UK St. Georges University of London
Shankar Subramaniam US University of California San Diego
Robin Weiss UK University College London
Douglas Young UK Imperial College London
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account